CVAC
CureVac (CVAC)
$82
About CureVac (CVAC)
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.
Details
Daily high
$4.98
Daily low
$4.77
Price at open
$4.97
52 Week High
$5.72
52 Week Low
$2.48
Market cap
1.1B
Dividend yield
0.00%
Volume
1.7M
Avg. volume
1.8M
P/E ratio
6.96
CureVac News
Details
Daily high
$4.98
Daily low
$4.77
Price at open
$4.97
52 Week High
$5.72
52 Week Low
$2.48
Market cap
1.1B
Dividend yield
0.00%
Volume
1.7M
Avg. volume
1.8M
P/E ratio
6.96